The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

18F-FDG     (2S,3R,4S,5S,6R)-3-fluoro-6...

Synonyms: Flucis, SureCN135994, CHEBI:31617, MOLI000964, AC1L9OYT, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Fludeoxyglucose F 18


High impact information on Fludeoxyglucose F 18

  • CONCLUSIONS: Global or absolute measures of metabolism using positron emission tomography and fludeoxyglucose F18 did not statistically differentiate between normal adolescents with ADHD [9].
  • Of the publications retrieved by these text words, only 4% were indexed by the MeSH term "Fludeoxyglucose F18" in Medline and 29% by the MeSH-term "Fluorodeoxyglucose F18" in Embase [10].
  • METHODS: Seven subjects with histories of extremely violent behavior were studied with positron emission tomography (PET) with fludeoxyglucose F 18 (FDG), brain electrical area mapping, MR imaging, neuropsychiatric and neuropsychological testing, and clinical examination during medical evaluation associated with legal proceedings [11].

Psychiatry related information on Fludeoxyglucose F 18

  • Our study demonstrated that vascular 18F-FDG uptake is reversed in response to atherogenic risk reduction by lifestyle intervention and that the magnitude of improvement correlates to increases in plasma HDL levels [12].

Chemical compound and disease context of Fludeoxyglucose F 18


Associations of Fludeoxyglucose F 18 with other chemical compounds

  • The findings of this study suggest that further assessment of 131I WBS-negative, thyroglobulin-positive patients by 18F-FDG PET/CT may aid in the clinical management of selected cases regardless of the thyroglobulin level [13].
  • Cardiac 18F-FDG uptake was lower in patients receiving bezafibrate and levothyroxine and higher in patients receiving benzodiazepines [14].


  1. Diagnosis of recurrent astrocytoma with fludeoxyglucose F18 PET scanning. Mirzaei, S., Knoll, P., Kohn, H. N. Engl. J. Med. (2001) [Pubmed]
  2. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Turlakow, A., Yeung, H.W., Pui, J., Macapinlac, H., Liebovitz, E., Rusch, V., Goy, A., Larson, S.M. Arch. Intern. Med. (2001) [Pubmed]
  3. Preoperative FDG-PET for axillary metastases in patients with breast cancer. Chung, A., Liou, D., Karlan, S., Waxman, A., Fujimoto, K., Hagiike, M., Phillips, E.H. Archives of surgery (Chicago, Ill. : 1960) (2006) [Pubmed]
  4. 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer. Pauleit, D., Zimmermann, A., Stoffels, G., Bauer, D., Risse, J., Flüss, M.O., Hamacher, K., Coenen, H.H., Langen, K.J. J. Nucl. Med. (2006) [Pubmed]
  5. Low efficacy of 18F-FDG PET for detection of uveal malignant melanoma compared with 123I-IMP SPECT. Kato, K., Kubota, T., Ikeda, M., Tadokoro, M., Abe, S., Nakano, S., Nishino, M., Kobayashi, H., Ishigaki, T. J. Nucl. Med. (2006) [Pubmed]
  6. Clinical utility of 18F-FDG PET for patients with salivary gland malignancies. Roh, J.L., Ryu, C.H., Choi, S.H., Kim, J.S., Lee, J.H., Cho, K.J., Nam, S.Y., Kim, S.Y. J. Nucl. Med. (2007) [Pubmed]
  7. Rapid reduction of sigma1-receptor binding and 18F-FDG uptake in rat gliomas after in vivo treatment with doxorubicin. van Waarde, A., Shiba, K., de Jong, J.R., Ishiwata, K., Dierckx, R.A., Elsinga, P.H. J. Nucl. Med. (2007) [Pubmed]
  8. The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions. Mavi, A., Cermik, T.F., Urhan, M., Puskulcu, H., Basu, S., Yu, J.Q., Zhuang, H., Czerniecki, B., Alavi, A. J. Nucl. Med. (2007) [Pubmed]
  9. Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Zametkin, A.J., Liebenauer, L.L., Fitzgerald, G.A., King, A.C., Minkunas, D.V., Herscovitch, P., Yamada, E.M., Cohen, R.M. Arch. Gen. Psychiatry (1993) [Pubmed]
  10. How to perform a comprehensive search for FDG-PET literature. Mijnhout, G.S., Hooft, L., van Tulder, M.W., Devillé, W.L., Teule, G.J., Hoekstra, O.S. European journal of nuclear medicine. (2000) [Pubmed]
  11. Abnormal temporal lobe metabolism in violent subjects: correlation of imaging and neuropsychiatric findings. Seidenwurm, D., Pounds, T.R., Globus, A., Valk, P.E. AJNR. American journal of neuroradiology. (1997) [Pubmed]
  12. Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction. Lee, S.J., On, Y.K., Lee, E.J., Choi, J.Y., Kim, B.T., Lee, K.H. J. Nucl. Med. (2008) [Pubmed]
  13. 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer. Shammas, A., Degirmenci, B., Mountz, J.M., McCook, B.M., Branstetter, B., Bencherif, B., Bencherif, B.B., Joyce, J.M., Carty, S.E., Kuffner, H.A., Avril, N. J. Nucl. Med. (2007) [Pubmed]
  14. PET/CT quantitation of the effect of patient-related factors on cardiac 18F-FDG uptake. Israel, O., Weiler-Sagie, M., Rispler, S., Bar-Shalom, R., Frenkel, A., Keidar, Z., Bar-Shalev, A., Strauss, H.W. J. Nucl. Med. (2007) [Pubmed]
WikiGenes - Universities